Ozempic vs. Qsymia

See how Ozempic and Qsymia compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Ozempic is a once-weekly injectable GLP-1 medicine for type 2 diabetes with added heart and kidney benefits, while Qsymia is a once-daily pill approved specifically for chronic weight management.

  • Ozempic's most common side effects are gastrointestinal, like nausea and vomiting, while Qsymia's most common effects are paresthesia, dry mouth, and dizziness from its stimulant and anticonvulsant combination.

  • Qsymia costs substantially less out of pocket than Ozempic, but it requires REMS pharmacy enrollment and carries a controlled-substance classification that Ozempic does not.

Ozempic vs. Qsymia Drug Summary

Ozempic

Ozempic is a GLP-1 receptor agonist approved to improve blood sugar control in adults with type 2 diabetes, and it also lowers cardiovascular and kidney risks in people with related conditions. It is given as a once-weekly injection under the skin, with the dose slowly increased over several weeks. Some doctors prescribe it off-label for weight loss, though that use belongs officially to Wegovy.

Qsymia

Qsymia combines phentermine, a stimulant that suppresses appetite, with topiramate, an anticonvulsant, in one extended-release capsule for chronic weight management. It is approved for adults with obesity or excess weight plus a related health condition, and for adolescents 12 and older with obesity. The dose is taken once daily and titrated upward over about 16 weeks based on weight loss response.

Ozempic vs. Qsymia Side Effects

Ozempic

Most common
Nausea (up to 20.3%)
Vomiting (up to 9.2%)
Diarrhea (up to 8.8%)
Constipation (up to 5.0%)

Qsymia

Most common
Paresthesia (up to 21%)
Dry mouth (up to 19%)
Constipation (up to 16%)
Insomnia (up to 11%)

Ozempic vs. Qsymia Dosage

Ozempic

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 mg once weekly Weeks 1-4
Maximum dose 0.5 mg once weekly Week 5 onward
Dose changes 1 increase Every 4 weeks

Qsymia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 3.75 mg/23 mg once daily Days 1-14
Maximum dose 15 mg/92 mg once daily Week 17 onward
Dose changes 3 increases As tolerated

Ozempic vs. Qsymia Indications

Ozempic

Ozempic is FDA-approved to help adults with type 2 diabetes manage blood sugar alongside diet and exercise. In patients who also have heart disease, it lowers the risk of heart attack, stroke, and cardiovascular death, and in those with chronic kidney disease it slows further kidney damage. It is not FDA-approved for weight loss, though many clinicians prescribe it that way off-label.

  • Type 2 diabetes blood sugar control

  • Cardiovascular risk reduction with heart disease

  • Slows chronic kidney disease progression

  • Off-label weight loss (not FDA-approved for this use)

Qsymia

Qsymia is FDA-approved specifically for chronic weight management, not diabetes or heart disease. It's used in adults with obesity, or who are overweight with a weight-related condition like high blood pressure or high cholesterol, and in adolescents 12 and older with obesity. Doctors evaluate weight loss at set checkpoints during the dose titration to confirm the medication is working.

  • Chronic weight management in adults with obesity

  • Weight management with a weight-related condition

  • Weight management in adolescents 12 and up

  • Requires periodic weight-loss check-ins during titration

Ozempic vs. Qsymia Pros and Cons

Ozempic

Ozempic offers once-weekly dosing and added cardiovascular and kidney benefits beyond blood sugar control, backed by large outcomes trials. It requires an injection and carries a boxed warning, and it is not FDA-approved for weight loss despite common off-label use.

Pros

  • Only one injection needed per week

  • Also reduces cardiovascular risk in heart disease

  • Also slows chronic kidney disease progression

  • Not a controlled substance, no REMS needed

Cons

  • Common GI side effects like nausea and vomiting

  • Boxed warning for thyroid C-cell tumors

  • Not FDA-approved for weight loss (off-label use)

  • Roughly $935 to $1,043 per month without insurance

Qsymia

Qsymia is taken as a daily pill and is specifically FDA-approved for weight loss, with a lower list price than many injectable options. It requires REMS enrollment, monthly pregnancy testing, and carries a controlled-substance classification with abuse potential.

Pros

  • Taken as a daily pill, no injections

  • FDA-approved specifically for weight management

  • Roughly $200 to $350 per month without insurance

  • Available for adolescents 12 and older

Cons

  • Requires REMS enrollment and certified pharmacies

  • Schedule IV controlled substance, misuse potential

  • Not safe in pregnancy; monthly pregnancy tests required

  • Risk of mood, sleep, and cognitive side effects

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.